Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP To Help Set Formulary Rules Under Medicare Rx Bill

Executive Summary

The U.S. Pharmacopeia would play a central role in setting the ground rules for formularies under the Medicare prescription drug bill

You may also be interested in...



Formulary Payments From Manufacturers To PBMs Reviewed By FTC

Contract agreements between pharmacy benefit managers and pharmaceutical manufacturers do not typically demonstrate higher payment allowances for drugs dispensed through PBM-owned mail order pharmacies compared to retail pharmacies, according to a Federal Trade Commission report

Formulary Payments From Manufacturers To PBMs Reviewed By FTC

Contract agreements between pharmacy benefit managers and pharmaceutical manufacturers do not typically demonstrate higher payment allowances for drugs dispensed through PBM-owned mail order pharmacies compared to retail pharmacies, according to a Federal Trade Commission report

Pharmacy Access Laws Would Increase Drug Costs, FTC Says

Bills pending in Rhode Island that would require insurance plans to have open pharmacy networks would likely result in increased costs to consumers, the Federal Trade Commission said

Related Content

UsernamePublicRestriction

Register

PS042895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel